SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001558370-23-011082
Filing Date
2023-06-14
Accepted
2023-06-14 16:35:18
Documents
12
Period of Report
2023-06-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A agrx-20230608x8ka.htm   iXBRL 8-K/A 37493
  Complete submission text file 0001558370-23-011082.txt   157688

Data Files

Seq Description Document Type Size
2 EX-101.SCH agrx-20230608.xsd EX-101.SCH 3159
3 EX-101.LAB agrx-20230608_lab.xml EX-101.LAB 15926
4 EX-101.PRE agrx-20230608_pre.xml EX-101.PRE 10130
6 EXTRACTED XBRL INSTANCE DOCUMENT agrx-20230608x8ka_htm.xml XML 4812
Mailing Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635
Business Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36464 | Film No.: 231014605
SIC: 2834 Pharmaceutical Preparations